Biomedical Engineering Reference
In-Depth Information
(c)
(a)
β
γ
α
α + β + γ
β + γ
β β
(b)
β
γ
α
α + β + γ
β + γ
β β
β
γ
α
α + β + γ
β + γ
β β
αα
α
α α
αα
α
α α
α α
α
α α
v
iv
iv
iv
iii
iii
iii
ii
ii
ii
i
i
i
1500 1400 1300 1200 1100 1000 900
800
700
600
500
400
1500 1400 1300 1200 1100 1000 900
800
700
600
500
400
1500 1400 1300 1200 1100 1000 900
800
700
600
500
400
Wavenumber (cm 1 ) Wavenumber (cm 1 )
Wavenumber (cm 1 )
1.6
1.6
1.6
(d) (e)
(f)
β -phase
γ -phase
α -phase
1.4
1.4
1.4
1.2
1.2
1.2
1.0
1.0
1.0
0.8
0.8
0.8
β
-phase
β -phase
γ -phase
α -phase
0.0
0.0
0.0
γ
-phase
α -phase
0.4
0.4
0.4
0.2
0.2
0.2
0.0
0.0
0.0
0
0.01
0.03
0.05
5e-3
PVDF cast film
0
0.25
0.5
0.75
PVDF nano fiber
0
0.01
0.02
MWCNT (wt.-%) in PVDF electrospun nanofiber
CaCl 2 (wt.-%) in PVDF electrospun nanofiber
MWCNT (wt.-%) in PVDF-CaCl 2
(0.5 wt.-%) electrospun nanofiber
Figure 8.6 FTIR-TS of electrospun fibers (a) PVDF-CaCl 2 : (i) PVDF solution-cast film (used for comparison here), (ii) 0, (iii) 0.25, (iv) 0.5,
and (v) 0.75 wt% of CaCl 2 ; (b) PVDF-MWCNT: (i) 0, (ii) 0.01, (iii) 0.03, and (iv) 0.05 wt% of MWCNT; (c) PVDF-CaCl 2 (0.5 wt%) + varying
content of MWCNT: (i) 0, (ii) 0.005, (iii) 0.01, and (iv) 0.02 wt%; relative amount of crystalline phases as a function of additive in PVDF
electrospun samples: (d) with varying CaCl 2 content; (e) with varying MWCNT content; and (f) with CaCl 2 (0.5 wt%) + varying MWCNT
content.
Search WWH ::




Custom Search